Cleared Traditional

K982520 - CEFONICID ANTIMICROBIAL SUSCEPTIBILITY ...

K982520 is an FDA 510(k) clearance for CEFONICID ANTIMICROBIAL SUSCEPTIBILITY ..., manufactured by Oxoid , Ltd.. The device is a Class 2 Microbiology device with product code JTN cleared through the Traditional 510(k) pathway after a 51-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1998
Decision
51d
Days
Class 2
Risk

K982520 is an FDA 510(k) clearance for the CEFONICID ANTIMICROBIAL SUSCEPTIBILITY TEST DISC. Classified as Susceptibility Test Discs, Antimicrobial (product code JTN), Class II - Special Controls.

Submitted by Oxoid , Ltd. (Basingstoke, GB). The FDA issued a Cleared decision on September 9, 1998 after a review of 51 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.1620 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Oxoid , Ltd. devices

FDA 510(k) Submission Details - K982520

510(k) Number K982520 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 20, 1998
Decision Date September 09, 1998
Days to Decision 51 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
51d faster than avg
Panel avg: 102d · This submission: 51d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JTN Device Classification - Class 2, Special Controls

Product Code JTN Susceptibility Test Discs, Antimicrobial
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.1620
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - JTN Susceptibility Test Discs, Antimicrobial

All 313
Devices cleared under the same product code (JTN) and FDA review panel - the closest regulatory comparables to K982520.
MEROPENEM ANTIMICROBIAL SUSCEPTIBILITY TEST DISC
K983718 · Oxoid , Ltd. · Dec 1998
CEFPROZIL ANTIMICROBIAL SUSCEPTIBILITY TEST DISC
K982517 · Oxoid , Ltd. · Sep 1998
LEVOFLOXACIN ANTIMICROBIAL SUSCEPTIBILITY TEST DISC
K982519 · Oxoid , Ltd. · Sep 1998
SULFISOXAZOLE ANTIMICROBIAL SUSCEPTIBILITY TEST DISC
K982523 · Oxoid , Ltd. · Sep 1998
AMOXICILLIN/CLAVULANIC ACID ANTIMICROBIAL SUSCEPTIBILITY TEST DISC
K982524 · Oxoid , Ltd. · Sep 1998
SPARFLOXACIN ANTIMICROBIAL SUSCEPTIBILITY TEST DISC
K982526 · Oxoid , Ltd. · Sep 1998